"Senders Pediatrics, serving Cleveland and Northeast Ohio, offers comprehensive medical and behavioral care for children of all ages. We serve newborns, adolescents and young adults and offer breastfeeding guidance and care. Evening and weekend hours. Most insurance accepted."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Senders Pediatrics
During the past decade, Senders Pediatrics conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2%
of trials that started reached the finish line.
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
2010-06-01
Active, not recruiting
2,527
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Senders Pediatrics" #1 sponsor was "Pfizer" with 5 trials, followed by "BioNTech SE" with 4 trials
sponsored, "Affinivax, Inc." with 1 trials sponsored, "MedImmune LLC" with 1 trials sponsored and "ModernaTX, Inc."
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Senders Pediatrics"
#1 collaborator was "Pfizer" with 4 trials as a collaborator and "GlaxoSmithKline" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Senders Pediatrics
According to Clinical.Site data, the most researched conditions in "Senders Pediatrics" are
"COVID-19" (4 trials), "SARS-CoV-2 Infection" (3 trials), "Meningococcal Vaccines" (2 trials), "Pneumococcal Infections" (2 trials) and "Vaccines" (2 trials). Many other conditions were trialed in "Senders Pediatrics" in a lesser frequency.
Clinical Trials Intervention Types at Senders Pediatrics
Most popular intervention types in "Senders Pediatrics" are "Biological" (13 trials) and "Other" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "BNT162b2" (2 trials), "MenABCWY" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials) and "13vPnC" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Senders Pediatrics
The vast majority of trials in "Senders Pediatrics" are
13 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Senders Pediatrics
Currently, there are NaN active trials in "Senders Pediatrics".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Senders Pediatrics,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Senders Pediatrics, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".